NASDAQ: BBIO
BridgeBio Pharma Inc Stock

$10.48+0.18 (+1.75%)
Updated Jan 24, 2022
BBIO Price
$10.48
Fair Value Price
N/A
Market Cap
$1.54B
52 Week Low
$9.23
52 Week High
$73.50
P/E
-2.68x
P/B
-2.07x
P/S
120.7x
PEG
N/A
Dividend Yield
N/A
Revenue
$56.95M
Earnings
-$535.34M
Gross Margin
97.3%
Operating Margin
-865.18%
Profit Margin
-940%
Debt to Equity
-2.04
Operating Cash Flow
-$460M
Beta
1.01
Next Earnings
Feb 23, 2022
Ex-Dividend
N/A
Next Dividend
N/A

BBIO Overview

Zen Score

High
Medium
Low
Industry Average (19)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BBIO scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BBIO's cash and short-term investments ($599.61M) can cover BBIO's cash burn for the next year ($473.16M), even accounting for increasing cash burn (N/A)
Financials
BBIO's profit margin has increased (+892.7%) in the last year from (-1,832.7%) to (-940%), but it is still unprofitable
Financials
BBIO's short-term assets ($639.71M) exceed... subscribe to Premium to read more.
Financials
There are 13 more BBIO due diligence checks available for Premium users.

BBIO News

Valuation

BBIO fair value

Fair Value of BBIO stock based on Discounted Cash Flow (DCF)
Price
$10.48
Fair Value
$11.53
Undervalued by
9.10%

BBIO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.68x
Industry
20.6x
Market
34.17x

BBIO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-2.07x
Industry
4.59x

BBIO's financial health

Profit margin

Revenue
$2.3M
Net Income
-$155.9M
Profit Margin
-6,652.5%
BBIO's cash and short-term investments... subscribe to Premium to read more.
Financials
BBIO's profit margin has increased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$781.5M
Liabilities
$1.5B
Debt to equity
-2.04
BBIO's short-term assets ($639.71M) exceed... subscribe to Premium to read more.
Financials
BBIO's long-term liabilities ($1.42B) exceed... subscribe to Premium to read more.
Financials
BBIO's debt relative to shareholder... subscribe to Premium to read more.
Financials
BBIO's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
-$121.6M
Investing
$59.0M
Financing
-$135.5M
BBIO's cash and short-term investments... subscribe to Premium to read more.
Financials

BridgeBio Pharma Stock FAQ

What is BridgeBio Pharma's quote symbol?

(NASDAQ: BBIO) BridgeBio Pharma trades on the NASDAQ under the ticker symbol BBIO. BridgeBio Pharma stock quotes can also be displayed as NASDAQ: BBIO.

What is the 52 week high and low for BridgeBio Pharma (NASDAQ: BBIO)?

(NASDAQ: BBIO) BridgeBio Pharma's 52-week high was $73.50, and its 52-week low was $9.23. It is currently -85.74% from its 52-week high and 13.54% from its 52-week low.

How much is BridgeBio Pharma stock worth today?

(NASDAQ: BBIO) BridgeBio Pharma currently has 147,166,573 outstanding shares. With BridgeBio Pharma stock trading at $10.48 per share, the total value of BridgeBio Pharma stock (market capitalization) is $1.54B.

BridgeBio Pharma stock was originally listed at a price of $27.55 in Jun 27, 2019. If you had invested in BridgeBio Pharma stock at $27.55, your return over the last 2 years would have been -61.96%, for an annualized return of -38.32% (not including any dividends or dividend reinvestments).

How much is BridgeBio Pharma's stock price per share?

(NASDAQ: BBIO) BridgeBio Pharma stock price per share is $10.48 today (as of Jan 24, 2022).

What is BridgeBio Pharma's Market Cap?

(NASDAQ: BBIO) BridgeBio Pharma's market cap is $1.54B, as of Jan 25, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

BridgeBio Pharma's market cap is calculated by multiplying BBIO's current stock price of $10.48 by BBIO's total outstanding shares of 147,166,573.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.